AACE Obesity Pharmacotherapy: BMI 27+ With Comorbidity Rule
AACE, ADA, and Endocrine Society allow obesity drugs at BMI ≥30, or BMI ≥27 with a comorbidity. See how guidelines compare on thresholds and treatment eligibility.
Obesity (Condition)
11 source-based articles maintained by the HealthRX.com Editorial Team.
11articles
3topic areas covered
Jul 10, 2025latest review
Obesity (Condition) library
Showing 11 of 11 clinical reviews.
Comorbidities of Obesity: Diabetes, Heart Disease, Sleep Apnea
Obesity (BMI ≥30) raises risk for 200+ conditions, most notably type 2 diabetes, heart disease, sleep apnea, MASLD, and osteoarthritis. See how they overlap.
Exercise Prescription for Obesity (BMI ≥30): Evidence-Based Protocols and Guidelines
A guide to exercise prescription for adults with obesity (BMI ≥30), covering AHA, ACSM, and Endocrine Society recommendations with specific protocols, doses, and trial data.
NIH Obesity Guidelines: 500-750 kcal/Day Deficit Explained
NIH first-line obesity treatment: a 500-750 kcal/day deficit plus 150-300 min/week exercise, yielding 5-10% weight loss in 6 months to cut cardiometabolic risk.
Obesity (BMI ≥30) Caregiver and Family Resources
Evidence-based guide to caregiver support, family-based interventions, and practical resources for managing obesity (BMI ≥30), including behavioral strategies, medication awareness, and clinical guidelines from ADA, AACE, and the Endocrine Society.
Obesity (BMI ≥30) Exact Monitoring Schedule
A guideline-backed monitoring schedule for adults with obesity (BMI ≥30), covering lab work, vitals, metabolic panels, and follow-up intervals during pharmacotherapy and lifestyle intervention.
Obesity (BMI ≥30): Emerging Research and Trials to Watch
A clinical review of the most promising obesity trials, next-generation GLP-1 receptor agonists, combination therapies, and gene-based approaches reshaping how we treat BMI ≥30.
Obesity Genetics and Family History: What Your DNA Means for Weight and Treatment
How genetics and family history influence obesity risk, BMI heritability, known gene variants like MC4R and FTO, and what this means for GLP-1 and other treatments.
Obesity Treatment Algorithm: A Line-by-Line Guide to Evidence-Based Therapy
Step-by-step obesity treatment algorithm organized by line of therapy, from lifestyle intervention through pharmacotherapy and metabolic surgery, based on ADA, AACE, and Endocrine Society guidelines.
Obesity Treatment in Special Populations: Evidence-Based Approaches for Complex Patients
How obesity management differs for older adults, adolescents, pregnant patients, and those with CKD, diabetes, or psychiatric conditions. Guideline-backed strategies with trial data.
Psychological Monitoring for Obesity Medications
Obesity raises depression risk 55%; depression raises obesity risk 58%. Learn what to monitor and how to treat both conditions together.